Rafa Laboratories Ltd. (TLV:RAFA)

Israel · Delayed Price · Currency is ILS · Price in ILA

1,804.00

0.00 (0.00%)

Nov 3, 2026, 2:14 PM IST

Market Cap	1.77B
Revenue (ttm)	459.86M -0.4%
Net Income	123.16M
EPS	0.04
Shares Out	97.98M
PE Ratio	418.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,846
Open	1,804.00
Previous Close	1,804.00
Day's Range	1,780.00 - 1,845.00
52-Week Range	1,401.00 - 1,999.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Rafa Laboratories

Rafa Laboratories Ltd., a pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel. The company offers sterile and aseptic injectable products, as well as formulations for combination devices such as auto-injectors. It also offers primary and secondary packaging solutions, including blisters, bottles, tubes, ampoules, cartridges, suppositories, and serialization services. In addition, it develops and offers auto-injector products for emergency use and protection against chem... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 1937

Employees 257

Stock Exchange Tel Aviv Stock Exchange

Ticker Symbol RAFA

Full Company Profile

Financial Performance

In 2025, Rafa Laboratories's revenue was 418.44 million, a decrease of -0.39% compared to the previous year's 420.08 million. Earnings were 100.34 million, an increase of 0.91%.

Financial Statements